Nitrofurantoin-induced lung disease and prophylaxis of urinary tract infections

被引:22
|
作者
Madani, Yasser [1 ]
Mann, Bhupinder [1 ]
机构
[1] W Middlesex Univ Hosp, Dept Resp Med, London TW7 6AF, England
来源
PRIMARY CARE RESPIRATORY JOURNAL | 2012年 / 21卷 / 03期
关键词
nitrofurantoin; lung disease; drug-induced; fibrosis; urinary tract infection; prophylaxis; PULMONARY-FIBROSIS;
D O I
10.4104/pcrj.2012.00059
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Nitrofurantoin is commonly used for the treatment and prophylaxis of recurrent urinary tract infections (UTIs). Although relatively rare, nitrofurantoin is one of the commonest causes of drug-induced pulmonary disease, which can be potentially serious and even fatal. Knowledge of such potential adverse effects is essential to enable early recognition and withdrawal of the drug. Patients on long-term nitrofurantoin should be reviewed and monitored regularly. Management involves early consideration of the condition, and prompt withdrawal of the drug. We report three cases of nitrofurantoin-induced lung disease in patients who were on long-term nitrofurantoin for UTI prophylaxis and present a brief review of the literature on this subject. (C) 2012 Primary Care Respiratory Society UK. All rights reserved. Y Madani and B Mann. Prim Care Respir J 2012; 21(3): 337-341 http://dx.doi.org/10.4104/pcrj.2012.00059
引用
收藏
页码:337 / 341
页数:5
相关论文
共 50 条
  • [41] Nitrofurantoin-Induced Pleural Effusion
    Amin, Hina
    Shawkat, Ahmed
    AMERICAN JOURNAL OF THERAPEUTICS, 2020, 27 (03) : E322 - E323
  • [42] NITROFURANTOIN-INDUCED AUTOIMMUNE HEPATITIS
    Yang, Xi
    Sohnen, Adam
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2021, 36 (SUPPL 1) : S342 - S343
  • [43] NITROFURANTOIN-INDUCED GRANULOMATOUS HEPATITIS
    STROHSCHEER, H
    WEGENER, HH
    MUNCHENER MEDIZINISCHE WOCHENSCHRIFT, 1977, 119 (47): : 1535 - 1536
  • [44] Nitrofurantoin-Induced Acute Pancreatitis
    Kayyali, Suhail
    Castineira, Janyll
    Upadhyay, Bhavik
    Beljic, Steven
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S729 - S729
  • [45] NITROFURANTOIN-INDUCED GRANULOMATOUS HEPATITIS
    SIPPEL, PJ
    AGGER, WA
    UROLOGY, 1981, 18 (02) : 177 - 178
  • [46] Nitrofurantoin 100 mg versus 50 mg prophylaxis for urinary tract infections, a cohort study
    ten Doesschate, Thijs
    Hendriks, Kelly
    van Werkhoven, Cornelis Henri
    van der Hout, Evelien C.
    Platteel, Tamara N.
    Groenewegen, Irene A. M.
    Muller, Anouk E.
    Hoepelman, Andy I. M.
    Bonten, Marc J. M.
    Geerlings, Suzanne E.
    CLINICAL MICROBIOLOGY AND INFECTION, 2022, 28 (02) : 248 - 254
  • [47] NITROFURANTOIN - CLINICAL AND LABORATORY STUDIES IN URINARY TRACT INFECTIONS
    RICHARDS, WA
    RISS, E
    KASS, EH
    FINLAND, M
    ARCHIVES OF INTERNAL MEDICINE, 1955, 96 (04) : 437 - 450
  • [48] Nitrofurantoin-induced lung disease: Two cases demonstrating resolution of apparently irreversible CT abnormalities
    Sheehan, RE
    Wells, AU
    Milne, DG
    Hansell, DM
    JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2000, 24 (02) : 259 - 261
  • [49] Presenting Features and Clinical Course of Chronic Nitrofurantoin-Induced Lung Toxicity
    Tzilas, Vasilios
    Charokopos, Antonios
    Kolilekas, Lykourgos
    Manali, Effrosyni
    Papiris, Spyridon
    Ryu, Jay H.
    Bouros, Demosthenes
    CHEST, 2022, 161 (03) : 748 - 752
  • [50] Nitrofurantoin-induced chronic active hepatitis
    Amit, G
    Cohen, P
    Ackerman, Z
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2002, 4 (03): : 184 - 186